Back
ProShares Ultra Nasdaq Cloud Computing Vs. Akero Therapeutics Industry Stock Comparison
Buy
83
SKYU
ProShares Ultra Nasdaq Cloud Computing
Last Price:
$32.75
Seasonality Move:
7.11%
Buy
68
AKRO
Akero Therapeutics
Last Price:
$54.26
Seasonality Move:
26.74%
Buy
83
ProShares Ultra Nasdaq Cloud Computing (SKYU)
is a Buy
Is ProShares Ultra Nasdaq Cloud Computing a Buy, Sell or Hold?
-
The current ProShares Ultra Nasdaq Cloud Computing [SKYU] share price is $32.80. The Score for SKYU is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
SKYU is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
68
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.28. The Score for AKRO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SKYU Stock Price Chart
What is ProShares Ultra Nasdaq Cloud Computing's stock price today?
-
The ProShares Ultra Nasdaq Cloud Computing share price today is $32.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SKYU is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
SKYU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 68.18 | Buy |
Chaikin Money Flow: | 361 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.27 - 32.05) | Buy |
Bollinger Bands (100): | (24.67 - 37.97) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.09 | Buy |
Relative Strength Index (14 RSI): | 70.44 | Buy |
Chaikin Money Flow: | -1219058 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.53 - 50.43) | Buy |
Bollinger Bands (100): | (34.89 - 51.35) | Buy |
SKYU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.4 | Buy |
20-day SMA: | 30.97 | Buy |
50-day SMA: | 26.74 | Buy |
200-day SMA: | 31.57 | Buy |
8-day EMA: | 31.64 | Buy |
20-day EMA: | 30.45 | Buy |
50-day EMA: | 29.3 | Buy |
200-day EMA: | 29.89 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.82 | Buy |
20-day SMA: | 46 | Buy |
50-day SMA: | 42.47 | Buy |
200-day SMA: | 36.08 | Buy |
8-day EMA: | 51.3 | Buy |
20-day EMA: | 47.76 | Buy |
50-day EMA: | 44.57 | Buy |
200-day EMA: | 37.75 | Buy |
ProShares Ultra Nasdaq Cloud Computing Earnings Growth & SKYU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
ProShares Ultra Nasdaq Cloud Computing Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |